论文部分内容阅读
目的 :为了探讨F14～F16微创经皮肾镜取石术 (MPCNL)治疗孤立肾肾结石的安全性与有效性 ;方法 :从 1998年 1月～ 2 0 0 3年 5月 ,利用微创PCNL技术治疗孤立肾肾结石 2 8例。结果 :2 8例患者中 ,合并肾积脓 6例 ,5例先行经皮肾穿刺造瘘术 ,5～ 7d后行二期经皮肾镜取石术 ,其余 2 3例患者均行一期取石 ,所有患者均为单通道取石 ,结石清除率 2 4例 ( 86% )。 1例孤肾肾结石合并积脓 ,行一期取石 ,术后出现中毒性休克 ,1例合并糖尿病患者术后出现酮症酸中毒 ,其余未出现大的并发症。结论 :微创PCNL治疗孤立肾肾结石是安全、有效 ,同时具有对病人创伤小 ,易恢复等优点
Objective: To investigate the safety and efficacy of F14 ~ F16 minimally invasive percutaneous nephrolithotomy (MPCNL) in the treatment of solitary kidney nephrolithiasis. METHODS: From January 1998 to May 2003, patients underwent minimally invasive PCNL Technical treatment of isolated kidney and kidney stones 28 cases. Results: Of the 28 patients, 6 cases were complicated with pyknosis of pyelonephritis, 5 cases were percutaneous nephrolithotomy, 5 cases were treated with percutaneous nephrolithotomy after 5 ~ 7 days, and the remaining 23 cases were treated with stage 1 stone , All patients were single-channel stone, stone clearance rate of 24 cases (86%). One case of kidney and kidney stones combined empyema, a line of stone, postoperative toxic shock, 1 case of diabetic patients with ketoacidosis, the rest did not appear large complications. Conclusions: Minimally invasive PCNL for the treatment of isolated kidney and kidney stones is safe and effective. At the same time, it has the advantages of small trauma and easy recovery